Läst 88 ggr
Virusvaccin mot cancer
En ny sorts vaccin som består av ett gentekniskt förändrat virus som dödar cancerceller går nu i fas 1 av studierna som krävs:
Imugene and City of Hope announce first patient dosed in Phase 1 trial to test cancer-killing oncolytic virus against solid tumors
Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors. The City of Hope-developed oncolytic virus has been shown to shrink colon, lung, breast, ovarian and pancreatic cancer tumors in preclinical laboratory and animal models.